Status:
RECRUITING
Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit
Lead Sponsor:
NYU Langone Health
Conditions:
Medication Administered in Error
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a randomized controlled study of parents of children to be discharged from the neonatal intensive care unit at Bellevue and Elmhurst hospitals. A total of 425 subjects will be recruited across...
Detailed Description
Our overarching goal is to promote safe medication use/adherence for high-risk infants, by leveraging health literacy approaches and mobile technology to reinforce provider counseling and support pare...
Eligibility Criteria
Inclusion
- English or Spanish-speaking
- 18 years of age and older
- Child discharged home with a Rx for \>1 daily liquid medication (other than multivitamin)
- Primary person who will administers child's medications.
- Willingness and ability to participate
Exclusion
- Does not have a working phone number
- Does not have access to internet (via computer/smartphone)
- Does not have a mobile phone that receives texts.
- Not able to return to the hospital for their child's follow-up visit
- Visual acuity worse than 20/50 according to the Rosenbaum Pocket Screener
- Uncorrectable hearing impairment
Key Trial Info
Start Date :
March 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
425 Patients enrolled
Trial Details
Trial ID
NCT04278690
Start Date
March 10 2021
End Date
February 1 2027
Last Update
August 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016